mg4101
Cell therapyexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2014 (NCT02008929)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Natural killer cellSupplementation
Natural killer cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mg4101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03578198 | Phase 2 | Aug 31, 2018 | Seoul National University |
| NCT03349502 | Phase 2 | Nov 1, 2017 | Seoul National University |
| NCT02854839 | Phase 2 | Sep 1, 2016 | Green Cross Corporation, Seoul National University |
| NCT02008929 | Phase 2 | Aug 1, 2014 | Sungkyunkwan University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seoul National University | Academic/Hospital | 3 | 2 | 1 | 2016 |
| Green Cross Corporation | For profit | 1 | 1 | 1 | 2016 |
| Sungkyunkwan University | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1